全文获取类型
收费全文 | 1100篇 |
免费 | 167篇 |
国内免费 | 134篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 20篇 |
妇产科学 | 35篇 |
基础医学 | 214篇 |
口腔科学 | 21篇 |
临床医学 | 75篇 |
内科学 | 309篇 |
皮肤病学 | 7篇 |
神经病学 | 62篇 |
特种医学 | 16篇 |
外科学 | 137篇 |
综合类 | 141篇 |
预防医学 | 36篇 |
眼科学 | 14篇 |
药学 | 66篇 |
1篇 | |
中国医学 | 8篇 |
肿瘤学 | 228篇 |
出版年
2024年 | 1篇 |
2023年 | 16篇 |
2022年 | 48篇 |
2021年 | 107篇 |
2020年 | 76篇 |
2019年 | 56篇 |
2018年 | 52篇 |
2017年 | 71篇 |
2016年 | 104篇 |
2015年 | 119篇 |
2014年 | 184篇 |
2013年 | 160篇 |
2012年 | 127篇 |
2011年 | 116篇 |
2010年 | 70篇 |
2009年 | 49篇 |
2008年 | 26篇 |
2007年 | 16篇 |
2006年 | 3篇 |
排序方式: 共有1401条查询结果,搜索用时 359 毫秒
41.
Amal S. El-Shal Nader M. Aly Sahar M. Abdel Galil Mohamed A. Moustafa Wael A. Kandel 《Joint, bone, spine : revue du rhumatisme》2013,80(6):626-631
ObjectiveTo investigate whether miRNA-499 (rs3746444) and miRNA-146a (rs2910164) genes polymorphisms are independent factors for rheumatoid arthritis (RA) in Egyptians, and whether they influence disease severity and activity.MethodsTwo hundred and seventeen RA patients and 245 healthy controls were enrolled in this study. Polymorphisms of miRNA-146a and miRNA-499 genes were detected using polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP).ResultsThe miRNA-499 CT genotype was an independent factor of RA. The miRNA-499 CT, CC genotypes and C allele frequencies were significantly increased in erosive RA group. Moreover, the heterozygote CT had more severe and more active form of the disease compared with homozygote CC or TT. However, we did not find any significant association of miRNA-146a polymorphism with RA risk, severity, and activity.ConclusionThe miRNA-499 polymorphism is an independent factor of RA, and influences disease severity and activity. 相似文献
42.
MicroRNA‐21 (miR‐21) expression in hypothermic machine perfusate may be predictive of early outcomes in kidney transplantation 下载免费PDF全文
Usman Khalid Elijah Ablorsu Laszlo Szabo Robert H. Jenkins Timothy Bowen Rafael Chavez Donald J. Fraser 《Clinical transplantation》2016,30(2):99-104
Hypothermic machine perfusion is effective in improving outcome following kidney transplantation. Molecular analyses of hypothermic machine perfusate (HMP) have the potential to identify biomarkers of organ viability prior to transplantation, offering significant advantages to the transplant surgeon, and leading to a potential increase in the organ donor pool. MicroRNAs are emerging as important biomarkers in the context of kidney injury and transplantation. Recent data demonstrate increased microRNA‐21 (miR‐21) expression in the kidney following acute kidney injury. This study investigated the potential of miR‐21 detected in HMP to act as a sentinel for early kidney transplant outcomes. MiR‐21 was found to be readily detectable in HMP by RT‐qPCR. Eleven ECD kidneys were maintained on a hypothermic machine perfusion system for a median 627 (range 117–1027) minutes, and evaluation of flow and resistance characteristics suggested stability on the machine from 60 min post‐perfusion. MiR‐21 quantification at 60 min post‐perfusion correlated with eGFR at 6 and 12 months post‐transplantation. These data suggest that miR‐21 expression in HMP may be predictive of early outcomes following kidney transplantation. In the era of ECD kidneys, a reliable measure of organ quality is urgently needed, and this study suggests miR‐21 may be such a marker. 相似文献
43.
44.
45.
46.
47.
Ulrika Segersten Yael Spector Yaron Goren Sarit Tabak Per-Uno Malmström 《Urologic oncology》2014,32(5):613-618
ObjectiveTo analyze microRNA profile in Ta and T1 urinary bladder cancers in combination and separately and to relate this to the risk of later developing higher-stage disease.Materials and methodsFormalin-fixed, paraffin-embedded samples of 44 Ta and 42 T1 bladder cancers representing cases with and without stage progression during follow-up were collected and microRNA expression levels were measured by microarray analysis.ResultsIn a comparison between the progressors and controls, in the Ta/T1 group, miR-10a-5p and miR-31-5p were differentially expressed. miR-10a-5p was also correlated to time to progression (P = 0.00012). In the subgroup analysis, 3 microRNAs, miR-10a-5p, miR-31-5p, and miR-130a-3p, were differentially expressed among Ta tumors and had a fold change of more than 1.5 (P<0.038). The comparison concerning microRNA expression between the progressors and controls in category T1 cancers revealed no significant differences.ConclusionsProfiling revealed that certain microRNAs predicted the risk of developing higher-stage disease among patients with Ta cancers. Lower miR-10a-5p expression in Ta progressing tumors indicates that this microRNA could be important for later malignant potential among this group of patients. 相似文献
48.
Zulfinaz Betul Celik Sengul Tural Ahmet Kivanc Cengiz Nurten Kara Gamze Alayli 《The Egyptian Rheumatologist》2021,43(1):35-39
Aim of the workTo investigate promoter methylation of matrix metalloproteinase-3 (MMP-3) and interleukin-16 (IL-16) genes with the expression of miRNA-93-5p and miRNA-4668-5p which target these genes in rheumatoid arthritis (RA), respectively.Patients and methodsThe study included 49 RA patients and 38 healthy controls. Promoter methylation of MMP-3 and IL-16 was analyzed by methylation-specific PCR. The expression of miRNA-93-5p and miRNA-4668-5p were determined. Disease activity score (DAS28) was assessed.ResultsThe 49 patients (38 female, 11 male) mean age was 50.4 ± 10.5 years and disease duration of 9.1 ± 7.4 years. The mean DAS28 was 3.9 ± 1.4. The MMP-3 gene methylation frequency was significantly lower in patients (n = 37;75.5%) compared to control (n = 37;97.4%) (p = 0.004) while they were comparable for IL-16 gene (n = 46;93.9% vs n = 37;97.4%)(p = 0.45). The relative normalized expression of miRNA-93-5p and miRNA-4668-5p were significantly increased (p < 0.001) in patients (2.28 ± 3.71 and 2.47 ± 4.17-fold) compared to controls (1.12 ± 0.18 and 1.28 ± 0.53-fold) and both tended to decrease with high disease activity (r = ? 0.104, p = 0.52; r = ?0.24, p = 0.15, respectively). There was no significant difference of miRNA-93-5p (p = 0.45), and miRNA-4668-5p (p = 0.26) expressions between patients receiving treatment and those not. A negative correlation was observed between disease activity and change in expression levels of miRNA-93-5p (r = ?0.104, p = 0.52) and miRNA-4668-5p (r = ?0.24, p = 0.15). The ROC curve analysis of target miRNAs showed the diagnostic potential of miRNA-93-5p and miRNA-4668-5p (p = 0.003 and p < 0.001 respectively).ConclusionsThe methylation status of MMP-3 promoter and expression levels of miRNA-93-5p and miRNA-4668-5p could be useful biomarkers for the pathogenesis of RA and might reflect disease activity. 相似文献
49.
目的 通过检测心房颤动(房颤)与窦性心律患者右心耳组织中microRNA-1、microRNA-133及microRNA-34a的表达差异,及其可能靶蛋白锚蛋白-B (Ankyrin-B )的表达变化,分析两者之间的关系,以从microRNAs调控水平研究房颤发生、发展的新机制。 方法 将第三军医大学新桥医院40例风湿性心瓣膜病行心瓣膜置换术患者分为房颤组[男8例,女12例;年龄(52.9±5.8)岁]和窦性心律组[男9例,女11例;年龄(52.4±6.2)岁] 。采用逆转录-实时定量聚合酶链式反应(RTQ-PCR,Real-time quantitive PCR)法检测患者右心耳组织中microRNA-1、microRNA-133及microRNA-34a的表达,ΔΔCt法计算结果;石蜡切片免疫组织化学法检测组织中Ankyrin-B的表达;蛋白免疫印迹(Western Blotting)法检测组织中Ankyrin-B的表达变化。 结果 房颤组患者右心房组织中的microRNA-1表达较窦性心律组显著降低(0.559±0.252 vs. 3.997±1.251;t =-21.455,P=0.000),microRNA-133的表达较窦性心律组显著降低(0.630±0.238 vs. 5.514±1.549;t =24.133,P=0.000),而microRNA-34a的表达较窦性心律组增高(4.783±2.012 vs. 1.350±0.638,t =12.596,P=0.000)。免疫组织化学法及Western Blotting均显示房颤组心房组织Ankyrin-B表达较窦性心律组明显降低,且差异有统计学意义(0.66±0.45 vs. 1.09±0.42;t =-3.396,P=0.001)。结论 MicroRNA-34a可能通过调节Ankyrin-B蛋白的表达,从而参与心房颤动的发生、发展。 相似文献
50.